You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Wednesday</strong> – Posters – 5183 – 5204<br />
5183 — B0338 Anti-Diuretic Hormone<br />
Arginine-Vasopressin Promotes an Increased<br />
Myopic Shift in Refractive Compensation to<br />
Optical Defocus in Physiologically Stressful<br />
Environmental Light Conditions. Melanie<br />
J. Murphy 1 , S. G. Crewther 1 , S. N. Kiely 1 , N.<br />
Riddell 1 , L. Giummarra 1 , D. P. Crewther 2 . 1 School<br />
of Psychological Science, La Trobe University,<br />
Melbourne, VIC, Australia; 2 Centre for Human<br />
Psychopharmacology, Swinburne University of<br />
Technology, Melbourne, VIC, Australia<br />
5184 — B0339 The expression of vaoactive<br />
intestinal peptide receptors and ZENK protein<br />
in form-deprivation myopia. Hikmet Basmak 1 ,<br />
H. Gursoy 1 , A. Cakmak 1 , N. Yildirim 1 , N. Tuncel 2 ,<br />
N. Erkasap 2 , M. Ozkurt 2 . 1 Dept of Ophthalmology,<br />
Eskisehir Osmangazi Univ Med Sch, Eskisehir,<br />
Turkey; 2 Physiology, Eskisehir Osmangazi Univ<br />
Med Sch, Eskisehir, Turkey *CR<br />
5185 — B0340 Effects of Adenosine A2A<br />
Receptor on the Development of Form-<br />
Deprivation Myopia in Mice. Jianhong An 1 ,<br />
X. Zhou 1 , F. Shi 1 , J. Chen 1, 2 , J. Qu 1 . 1 School of<br />
Ophthalmology & Optometry, Wenzhou Medical<br />
College, Wenzhou, Zhejiang, China; 2 Department of<br />
Neurology, Boston University School of Medicine,<br />
Boston, MA<br />
5190 — C0005 A Phase I/II Dose-Ranging,<br />
Randomized Clinical Trial of Abatacept<br />
(Orencia) in the Treatment of Refractory<br />
Non-Infectious Uveitis: Preliminary Results.<br />
Eric B. Suhler 1, 2 , T. R. Giles 2 , S. A. Hanel 2 , T. L.<br />
Liesegang 2 , R. M. Beardsley 2 , K. L. Larkin 2 , P. Lin 2 ,<br />
J. T. Rosenbaum 2, 3 . 1 Ophthalmology, Portland VA<br />
Medical Center, Portland, OR; 2 Ophthalmology,<br />
Casey Eye Institute-OHSU, Portland, OR;<br />
3<br />
Ophthalmology, Devers Eye Institute, Portland, OR<br />
*CR, f<br />
5191 — C0006 Effectiveness of anti-Tumor<br />
Necrosis Factor agents in Pediatric Population<br />
with Uveitis. Rula Hajj-ali 1 , M. M. Choudhary 2 ,<br />
A. Zeft 4 , S. Spalding 4 , S. K. Srivastava 3 , C. Y.<br />
Lowder 3 . 1 Orthopedics and Rheumatologic Institute,<br />
Cleveland Clinic Foundation, Cleveland, OH;<br />
2<br />
Internal Medicine, Cleveland Clinic Foundation,<br />
Cleveland, OH; 3 Ophthalmology, Cleveland<br />
Clinic Foundation, Cleveland, OH; 4 Pediatric<br />
Rheumatology, Cleveland Clinic Foundation,<br />
Cleveland, OH *CR<br />
5196 — C0011 Risk Factors Associated with<br />
Intraocular Pressure Rise in Patients with<br />
Uveitis Treated with the Fluocinolone Acetonide<br />
Implant. Anjali Parekh 1 , S. K. Srivastava 2 ,<br />
T. A. Albini 3 , Q. Nguyen 4 , D. A. Goldstein 1 .<br />
1<br />
Ophthalmology, Northwestern Medical Faculty<br />
Foundation, Chicago, IL; 2 Ophthalmology, Cole<br />
Eye Institute, Cleveland, OH; 3 Ophthalmology,<br />
Bascom Palmer Eye Institute, Miami, FL;<br />
4<br />
Ophthalmology, Wilmer Eye Institute, Baltimore,<br />
MD *CR, f<br />
5197 — C0012 Fluocinolone Acetonide<br />
Implants for Refractory Uveitis: a Retrospective<br />
Review. Harpal S. Sandhu, P. Pillai, G. N.<br />
Papaliodis. Ophthalmology, Massachusetts Eye and<br />
Ear Infirmary, Boston, MA<br />
5198 — C0013 Combination chemotherapy<br />
with Mycophenolate mofetil and Cyclosporin<br />
in recalcitrant uveitis. Reena A. Rasheed 1, 2 , G.<br />
T. Markov 1, 3 , C. Foster 1 . 1 Ocular Immunology,<br />
Massachussett’s Eye Research and Surgery<br />
Institution, Massachussetts, MA; 2 Regional Institute<br />
of Ophthalmology, Trivandrum, India; 3 University<br />
Eye Hospital, Pashev, Bulgaria *CR<br />
Exhibit Hall C0001-C0021<br />
<strong>Wednesday</strong>, May 08, 2013 2:45 PM-4:30 PM<br />
Immunology/Microbiology<br />
473 Non-infectious Inflammation<br />
Moderator: Kazuichi Maruyama<br />
5186 — C0001 Etiology of Non-infectious<br />
Uveitis Following Cataract Surgery. Zvi A.<br />
Kresch 1 , C. Yang 3 , V. Diaz 1 , S. Kedhar 1 , J. V.<br />
Mauro 2 , C. Samson 1 . 1 Ophthalmology, NY Eye and<br />
Ear, New York, NY; 2 North Shore Eye Care, New<br />
York, NY; 3 High School, Newark, NJ *CR<br />
5187 — C0002 Trends in Patterns of<br />
Intermediate Uveitis in a Tertiary Institution in<br />
Singapore. Helen Mi 1 , S. Ho 2 , W. Lim 2 , E. Wong 2 ,<br />
S. C. Teoh 2 . 1 Yong Loo Lin School of Medicine,<br />
National University of Singapore, Singapore,<br />
Singapore; 2 Ophthalmology, National Healthcare<br />
Group Eye Institute, Tan Tock Seng Hospital,<br />
Singapore, Singapore<br />
5188 — C0003 Epidemiology of Infectious<br />
Uveitis in Alabama. Christopher J. Compton,<br />
C. Huisingh, G. McGwin, R. W. Read, K. Beck.<br />
Ophthalmology, Univ of AL - Birmingham,<br />
Birmimgham, AL<br />
5189 — C0004 Characteristics of HLA-B27/<br />
Ankylosing Spondylitis Associated Uveitis in<br />
Different Ethnicities. Russell W. Read 1, 2 , K.<br />
Beck 1 . 1 Ophthalmology, University of Alabama<br />
at Birmingham, Birmingham, AL; 2 Pathology,<br />
University of Alabama at Birmingham,<br />
Birmingham, AL<br />
5192 — C0007 Multicenter study of TNF-a<br />
antagonists for refractory Behçet’s uveitis in<br />
Spain. Marina Mesquida 1 , D. Diaz-Valle 2 , M.<br />
Cordero Coma 3 , A. Fonollosa 4 , V. Llorens 1 , L.<br />
Pelegrin 1 , M. Hernandez 5 , G. Espinosa 6 , B. Molins 1 ,<br />
A. Adan Civera 1 . 1 Ophthalmology, Hospital Clinic<br />
de Barcelona, Barcelona, Spain; 2 Ophthalmology,<br />
Hospital Clinico San Carlos, Madrid, Spain;<br />
3<br />
Ophthalmology, Hospital de León, León, Spain;<br />
4<br />
Ophthalmology, Hospital Universitario Cruces,<br />
Bilbao, Spain; 5 Rheumatology, Hospital Clínic<br />
de Barcelona, Barcelona, Spain; 6 Autoimmune<br />
Disease, Hospital Clínic de Barcelona, Barcelona,<br />
Spain *CR<br />
5193 — C0008 Pharmacological blockade<br />
of interleukin 6 receptor (IL-6R) inhibits the<br />
development of ocular inflammation in the<br />
murine model of experimental autoimmune<br />
uveitis (EAU). Jingtai Cao, T. C. MacPherson, G.<br />
D. Yancopoulos, S. J. Wiegand. Ophthalmology,<br />
Regeneron Pharmaceuticals Inc, Tarrytown, NY<br />
*CR<br />
5194 — C0009 Treatment of Chronic,<br />
Persistent, Non-infectious, Non-granulomatous<br />
Uveitis in Patients with Juvenile Idiopathic<br />
Arthritis. Anton M. Kolomeyer 1 , Y. Tu 1 , N. V.<br />
Nayak 1 , E. Miserocchi 2 , D. S. Chu 1, 3 . 1 Institute of<br />
Ophthalmology and Visual Science, University<br />
of Medicine and Dentistry of NJ, Newark, NJ;<br />
2<br />
Department of Ophthalmology and Visual<br />
Sciences, Scientific Institute San Raffaele,<br />
University Vita-Salute, Milan, Italy; 3 Metropolitan<br />
Eye Research and Surgery Institute, Palisades Park,<br />
NJ *CR<br />
5195 — C0010 Characteristics of patients who<br />
attain remission of inflammatory eye disease<br />
following treatment and discontinuation of<br />
mycophenolate mofetil. Travis Jenkins, T. Truong,<br />
K. Lai, Z. A. Kresch, V. Diaz, J. V. Mauro, S.<br />
Kedhar, C. Samson. Ophthalmology, The New York<br />
Eye and Ear Infirmary, New York, NY *CR<br />
5199 — C0014 Macular thickness<br />
measurements with spectral domain optical<br />
coherence tomography during active episode of<br />
Unilateral Acute Anterior Uveitis. David Diaz-<br />
Valle, S. Garcia-Vidal, P. Arriola-Villalobos, R.<br />
Cuina, J. A. Gegundez-Fernandez, J. M. Benitezdel-Castillo.<br />
Ophthalmology, Hospital Clinico San<br />
Carlos, Madrid, Spain<br />
5200 — C0015 Evolution of intra ocular<br />
inflammation in treated acute anterior uveitis.<br />
Margaux Guillard 1 , E. Perrin 2 , B. Kirwan 2 , D.<br />
Monnet 1 , A. P. Brezin 1 . 1 Ophthalmology, Cochin<br />
Hospital - University Paris Descartes, Paris, France;<br />
2<br />
Socar Research SA, Nyon, Switzerland<br />
5201 — C0016 Use of Immunosuppressive<br />
Medications for Treatment of Pediatric<br />
Intermediate Uveitis. Spencer R. Cope 1 , A. O.<br />
Hersh 1 , A. Shakoor 2 , J. F. Bohnsack 1 , A. T. Vitale 2 .<br />
1<br />
Division of Pediatrics Rheumatology, University<br />
of Utah, Salt Lake City, UT; 2 Ophthalmology and<br />
Visual Sciences, John A. Moran Eye Center, Salt<br />
Lake City, UT *CR<br />
5202 — C0017 Genetic analysis of risk alleles<br />
associated with inflammatory bowel disease<br />
in acute anterior uveitis. Tammy M. Martin, P.<br />
Stauffer, E. Patridge, C. Younkins, M. Burcham, J.<br />
R. Smith. Ophthalmology, Oregon Health & Science<br />
Univ, Portland, OR<br />
5203 — C0018 Optic nerve spectral domain<br />
optical coherence tomography of papillitis<br />
secondary to uveitis. Parvathy Pillai, L. Sobrin.<br />
Ophthalmology, Massachusetts Eye and Ear<br />
Infirmary, Boston, MA<br />
5204 — C0019 Correlation between Disease<br />
Activity and Choroidal Patterns by OCT-EDI in<br />
Birdshot Chorioretinopathy. Andrea D. Birnbaum,<br />
A. A. Fawzi, L. M. Rifkin, D. A. Goldstein.<br />
Ophthalmology, Northwestern Univ Feinberg Sch<br />
of Med, Chicago, IL *CR<br />
<strong>Wednesday</strong> Posters<br />
2:45 pm – 4:30 pm<br />
f Refer to the Program Number in the Clinical Trial (CT) Registration Index. *CR Refer to the Program Number in the Commercial Relationships (CR) Index for Disclosures.<br />
331